Skip to content
Monday, November 16, 2026
Bingora Portal

Zimbabwe Declines ‘Unbalanced’ American Health Aid Agreement Because of Information Concerns

Health funding image
The proposed US funding was intended for initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has rejected a major American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over Washington's request for sensitive information.

The decision was revealed after a official document from December was disclosed, indicating that President Emmerson Mnangagwa believed the deal was "skewed".

A government spokesman later stated that the US was requesting biological samples for scientific study and commercial gain while was not willing to share the benefits from any future treatments.

"We are forced to start the challenging and unfortunate process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged continued negotiations to secure a deal acceptable to all parties so the nation's critical HIV treatment initiative can continue.

Wider Background

This rejection comes after a similar situation in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were raised about the safety of Kenyans' health data.

After returning to office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

USAID had managed aid for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral agreements to boost openness and responsibility.

According to reports, Sixteen nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn in new funding.

Specifics of the Rejected Agreement

The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," the Ambassador commented.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Our nation was requested to provide its biological resources and data over an extended period, without any equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," he stated.

"Put simply, our country would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our citizens if a new pandemic arise."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously set up through the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.

"This mechanism is intended to ensure that when a nation provides its samples, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to create them."

These objections over the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We are open to further discussions with our US partners on how subsequent collaboration might be structured in a way that honours the independence and dignity of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but recommended that negotiations must proceed given that a large portion of the nation's HIV programmes relied on international support.

"Where specific concerns exist, including those relating to data governance or implementation frameworks, these can often be resolved via technical clarification and mutually agreed protections," it added.

The halted deal emphasises the ongoing tensions between accepting vital international aid and protecting local interests in an ever more data-driven world.

AM
Written by

Andrew Mcmahon

A UK-based tech journalist with over a decade of experience covering digital transformation and startup ecosystems across Europe.

Bingora Portal

Type to search articles.